PL2190418T3 - Sposób dawkowania ibuprofenu o natychmiastowym i długotrwałym uwalnianiu - Google Patents

Sposób dawkowania ibuprofenu o natychmiastowym i długotrwałym uwalnianiu

Info

Publication number
PL2190418T3
PL2190418T3 PL07840963T PL07840963T PL2190418T3 PL 2190418 T3 PL2190418 T3 PL 2190418T3 PL 07840963 T PL07840963 T PL 07840963T PL 07840963 T PL07840963 T PL 07840963T PL 2190418 T3 PL2190418 T3 PL 2190418T3
Authority
PL
Poland
Prior art keywords
immediate
sustained release
dosage regimen
release ibuprofen
ibuprofen dosage
Prior art date
Application number
PL07840963T
Other languages
English (en)
Inventor
Der-Yang Lee
Frank Bunick
James Schwing
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of PL2190418T3 publication Critical patent/PL2190418T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2873—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL07840963T 2007-08-15 2007-08-15 Sposób dawkowania ibuprofenu o natychmiastowym i długotrwałym uwalnianiu PL2190418T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/839,168 US8137694B2 (en) 2007-08-15 2007-08-15 Immediate release and sustained release ibuprofen dosing regimen
EP07840963.8A EP2190418B1 (en) 2007-08-15 2007-08-15 Immediate release and sustained release ibuprofen dosing regimen
PCT/US2007/075990 WO2009023030A1 (en) 2007-08-15 2007-08-15 Immediate release and sustained release ibuprofen dosing regiment

Publications (1)

Publication Number Publication Date
PL2190418T3 true PL2190418T3 (pl) 2014-03-31

Family

ID=59676846

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07840963T PL2190418T3 (pl) 2007-08-15 2007-08-15 Sposób dawkowania ibuprofenu o natychmiastowym i długotrwałym uwalnianiu

Country Status (12)

Country Link
US (2) US8137694B2 (pl)
EP (2) EP2190418B1 (pl)
JP (1) JP5345620B2 (pl)
KR (1) KR101458774B1 (pl)
CN (1) CN101784262A (pl)
AU (4) AU2007357647A1 (pl)
BR (1) BRPI0721969A2 (pl)
CA (1) CA2696063C (pl)
ES (1) ES2438267T3 (pl)
MX (1) MX2010001789A (pl)
PL (1) PL2190418T3 (pl)
WO (1) WO2009023030A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2190418B1 (en) * 2007-08-15 2013-10-02 Mcneil-PPC, Inc Immediate release and sustained release ibuprofen dosing regimen
EP3417708B1 (en) * 2009-03-12 2020-06-17 Cumberland Pharmaceuticals, Inc. Administration of intravenous ibuprofen
US8735452B2 (en) * 2009-07-15 2014-05-27 Cumberland Pharmaceuticals Inc. Treating patients with intravenous ibuprofen
US8871810B2 (en) 2009-07-15 2014-10-28 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
CA2766367A1 (en) * 2009-07-31 2011-02-03 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
CN102160855B (zh) * 2011-03-30 2013-01-23 吴家安 右旋布洛芬缓释片及制备方法
CN102813638A (zh) * 2011-06-07 2012-12-12 贵阳医学院 一种右旋酮洛芬氨丁三醇双层缓释片的制备方法
WO2013103390A1 (en) * 2012-01-04 2013-07-11 Wellesley Pharmaceuticals, Llc Extended-release formulation for reducing the frequency of urination and method of use thereof
WO2013124768A1 (en) * 2012-02-20 2013-08-29 Lupin Limited Bilayer tablet of dronedarone
US9072661B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
US20140037725A1 (en) * 2012-08-01 2014-02-06 Cadila Healthcare Limited Bilayer pharmaceutical compositions of naproxen
EP3197436B1 (en) * 2014-09-24 2022-03-09 Vital Beverages Global Inc. Compositions and methods for selective gi tract delivery
CN108366969A (zh) * 2015-10-09 2018-08-03 拜尔健康护理有限责任公司 萘普生钠的改性释放制剂
US11364226B2 (en) 2017-06-30 2022-06-21 Cinrx Pharma, Llc Deuterated domperidone compositions, methods, and preparation
CN108697700B (zh) 2016-02-04 2021-08-17 辛多美制药有限公司 氘代多潘立酮组合物和用于治疗病症的方法
KR102636273B1 (ko) 2017-03-08 2024-02-16 신알엑스 파마, 엘엘씨 플로로글루시놀 및 트리메틸플로로글루시놀의 제약 제제
US12478612B2 (en) 2017-06-30 2025-11-25 Cindome Pharma, Inc. Deuterated domperidone compositions, methods, and preparation
TR201721036A2 (tr) * 2017-12-21 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Flurbi̇profeni̇n modi̇fi̇ye salimli formülasyonlari
CN110037994B (zh) * 2019-05-24 2022-04-12 中国药科大学 一种布洛芬速释缓释双层片及其制备方法
CN113842371A (zh) * 2021-10-11 2021-12-28 江苏集萃新型药物制剂技术研究所有限公司 一种双相释药组合物、双相释药固体药剂及其制备方法
CN119792240A (zh) * 2023-10-10 2025-04-11 上海云晟研新生物科技有限公司 布洛芬药物组合物、其制备方法及应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1497044A (en) * 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
US4873231A (en) 1986-04-08 1989-10-10 Smith Walton J Decreasing the toxicity of an ibuprofen salt
IT1200178B (it) 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
CA2061520C (en) 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
IT1264855B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
IT1264696B1 (it) 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
US6183778B1 (en) * 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
IT1276689B1 (it) 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale
US6004582A (en) * 1997-05-30 1999-12-21 Laboratorios Phoenix U.S.A, Inc. Multi-layered osmotic device
US6753009B2 (en) * 2002-03-13 2004-06-22 Mcneil-Ppc, Inc. Soft tablet containing high molecular weight polyethylene oxide
US20040186180A1 (en) 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
CA2519772C (en) 2003-03-21 2016-05-31 Mcneil-Ppc, Inc. Use of acetaminophen for providing a sustained therapeutic effect
EP2190418B1 (en) * 2007-08-15 2013-10-02 Mcneil-PPC, Inc Immediate release and sustained release ibuprofen dosing regimen

Also Published As

Publication number Publication date
JP2010536748A (ja) 2010-12-02
US8211465B2 (en) 2012-07-03
US20090048345A1 (en) 2009-02-19
AU2018201651B2 (en) 2019-01-03
JP5345620B2 (ja) 2013-11-20
AU2018201651A1 (en) 2018-03-29
ES2438267T3 (es) 2014-01-16
WO2009023030A1 (en) 2009-02-19
CN101784262A (zh) 2010-07-21
WO2009023030A8 (en) 2010-11-25
CA2696063A1 (en) 2009-02-19
AU2007357647A1 (en) 2009-02-19
HK1144071A1 (en) 2011-01-28
CA2696063C (en) 2014-05-06
AU2016203727A1 (en) 2016-06-23
EP2190418B1 (en) 2013-10-02
EP2190418A1 (en) 2010-06-02
AU2014203508A1 (en) 2014-07-17
US8137694B2 (en) 2012-03-20
EP2630955A1 (en) 2013-08-28
KR101458774B1 (ko) 2014-11-07
EP2630955B1 (en) 2021-09-22
US20120136060A1 (en) 2012-05-31
BRPI0721969A2 (pt) 2015-09-29
MX2010001789A (es) 2010-03-10
KR20100045509A (ko) 2010-05-03

Similar Documents

Publication Publication Date Title
PL2190418T3 (pl) Sposób dawkowania ibuprofenu o natychmiastowym i długotrwałym uwalnianiu
EP1992348A4 (en) PHARMACEUTICAL COMBINATION
LTPA2018005I1 (lt) Farmacinė kompozicija
DK2399579T3 (da) Farmaceutiske doseringsformer
PL2152237T3 (pl) Nowa kompozycja farmaceutyczna
ATE493119T1 (de) Pharmazeutische zusammensetzung
DK2061533T3 (da) Anordning til anvendelse i en terapi til leversygdom
IL199191A0 (en) Modified release ibuprofen solid oral dosage form
BRPI0813647A2 (pt) Piperazinil oxoalquil tetrahidro-beta-carbolinas e análogos relacionados
DK2077729T3 (da) Orale probiotiske doseringsformer
IL212802A (en) Lipids and compositions for the delivery of therapeutics
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
IL204528A (en) Pharmaceutical dosage forms for immediate sustained release of metadoxin
BRPI0820381A2 (pt) Formulações farmacêuticas
HRP20180718T1 (hr) Oligopeptidni spojevi i njihova upotreba
BRPI0913822A2 (pt) forma farmacêutica oral e uso da forma farmacêutica
EP2001443A4 (en) GRANULES Formulation
IL234296B (en) Dosing regimen
BRPI0807421A2 (pt) Microrganismo recombinante
PT2209464E (pt) Composição farmacêutica antimalárica
EP2193795A4 (en) AQUEOUS PHARMACEUTICAL COMPOSITION CONTAINING LATANOPROST
EP2341047A4 (en) CYCLOHEXANE DERIVATIVE AND ITS PHARMACEUTICAL USE
DE602008005137D1 (de) Chinolonverbindung und pharmazeutische zusammensetzung
ATE480227T1 (de) Pharmazeutische zusammensetzungen mit quetiapinfumarat
EP2156832A4 (en) PHARMACEUTICAL COMPOSITION